Sophia Genetics SA (SOPH) CHF0.05

Sell:$3.61Buy:$3.65$0.03 (0.85%)

NASDAQ:1.35%
Market closed | Prices delayed by at least 15 minutes
Sell:$3.61
Buy:$3.65
Change:$0.03 (0.85%)
Market closed | Prices delayed by at least 15 minutes
Sell:$3.61
Buy:$3.65
Change:$0.03 (0.85%)
Market closed | Prices delayed by at least 15 minutes

Company Information

About this company

Sophia Genetics SA is a Switzerland-based company engaged in the software publishing sector. The Company offer a cloud-based Software-as-a-Service platform - the SOPHiA DDM, which is data-driven medicine platform enabling insights from disparate, complex datasets to improve diagnosis, treatment, and drug development. The Company has offices in Switzerland, France and the United Kingdom and operates worldwide.

Key people

Ross Muken
President
Jurgi Camblong
Chief Executive Officer, Co-Founder, Director
George A. Cardoza
Chief Financial Officer
Manuela Da Silva Valente
Chief People Officer
Zhenyu Xu
Chief Scientific Officer
Philippe Menu
Chief Medical Officer
Daan Van Well
Chief Legal Officer
Troy M. Cox
Non-Executive Independent Chairman of the Board
Tomer Berkovitz
Non-Executive Independent Director
Kathy Hibbs
Non-Executive Independent Director
Didier Hirsch
Non-Executive Independent Director
Vincent Ossipow
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    CH1125843347
  • Market cap
    $234.53m
  • Employees
    449
  • Shares in issue
    79.32m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.